Postmarketing surveillance indicates need for better education of patients taking alendronate.
D019386:Alendronate; D004164:Diphosphonates / Q000009:adverse effects*; D004935:Esophageal Diseases / Q000139:chemically induced*; D004941:Esophagitis / Q000139:chemically induced; D006801:Humans; D010353:Patient Education as Topic; D011358:Product Surveillance, Postmarketing; D014456:Ulcer / Q000139:chemically induced
D004164:Diphosphonates; D019386:Alendronate